Get started
Author

Ricardo Grieshaber‐Bouyer

Observed names: Grieshaber Bouyer, Ricardo, Grieshaber-Bouyer, Ricardo, R Grieshaber-Bouyer, R. Grieshaber-Bouyer, Ricardo Grieshaber-Bouyer, Ricardo Grieshaber-Boyer
Observed institutions: Boston University, Brigham and Women's Hospital, Harvard University, Friedrich-Alexander-Universität Erlangen-Nürnberg, University of Zurich, Heidelberg University, University Hospital Heidelberg, Oklahoma Medical Research Foundation, University Hospital Regensburg, Ghent University, Universitätsklinikum Erlangen, Universitätsklinik Balgrist, European Molecular Biology Laboratory, VIB-UGent Center for Inflammation Research, Max Planck Institute of Biochemistry, European Molecular Biology Laboratory, Deutsche Gesellschaft für Rheumatologie und Klinische Immunologie e.V., University of Oklahoma Health Sciences Center, Otto-von-Guericke-Universität Magdeburg
ORCID: 0000-0002-2873-5135
Observed ORCID: 0000-0002-2873-5135
OpenAlex ID: A5065562343
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
2024 · Fabian Müller, Jule Taubmann, et al. · New England Journal of Medicine · 1,231
The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments
2021 · Ricardo Grieshaber-Bouyer, Felix A. Radtke, et al. · Nature Communications · 373
PDF
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
2024 · Carlo Tur, Markus Eckstein, et al. · Annals of the Rheumatic Diseases · 224
PDF
Bispecific T cell engager therapy for refractory rheumatoid arthritis
2024 · Laura Bucci, Melanie Hagen, et al. · Nature Medicine · 207
CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation
2017 · Ming Bai, Ricardo Grieshaber-Bouyer, et al. · Blood · 189
PDF
Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes
2021 · Evgeny Kiner, Elijah Willie, et al. · Nature Immunology · 175
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
2024 · Melanie Hagen, Laura Bucci, et al. · New England Journal of Medicine · 166
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series
2024 · Janina Auth, Fabian Müller, et al. · The Lancet Rheumatology · 150
Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease
2019 · Ricardo Grieshaber-Bouyer, Peter A. Nigrovic · Frontiers in Immunology · 143
PDF
Arthritis flares mediated by tissue-resident memory T cells in the joint
2021 · Margaret H. Chang, Anaïs Levescot, et al. · Cell Reports · 124
PDF
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study
2025 · Melanie Hagen, Fabian Müller, et al. · The Lancet Rheumatology · 115
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
2026 · Fabian Müller, Melanie Hagen, et al. · Nature Medicine · 112
PDF
IL-1β–driven osteoclastogenic Tregs accelerate bone erosion in arthritis
2021 · Anaïs Levescot, Margaret H. Chang, et al. · Journal of Clinical Investigation · 102
PDF
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells
2025 · Fabian Müller, Andreas Wirsching, et al. · Nature Medicine · 95
Human and mouse neutrophils share core transcriptional programs in both homeostatic and inflamed contexts
2023 · Nicolaj S. Hackert, Felix A. Radtke, et al. · Nature Communications · 95
PDF
ImmGen at 15
2020 · The Immunological Genome Project, Stephanie Vargas Aguilar, et al. · Nature Immunology · 83
PDF
CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus
2023 · Jule Taubmann, Fabian Müller, et al. · Arthritis & Rheumatology · 81
Effects of different B-cell-depleting strategies on the lymphatic tissue
2025 · Carlo Tur, Markus Eckstein, et al. · Annals of the Rheumatic Diseases · 75
PDF
Selective CAR T cell–mediated B cell depletion suppresses IFN signature in SLE
2024 · Artur Wilhelm, David Chambers, et al. · JCI Insight · 72
Effect of JAK Inhibition on the Induction of Proinflammatory HLA – DR + CD90 + Rheumatoid Arthritis Synovial Fibroblasts by Interferon‐γ
2021 · Shuyang Zhao, Ricardo Grieshaber‐Bouyer, et al. · Arthritis & Rheumatology · 71
From complexity to consensus: A roadmap for neutrophil classification
2025 · Lai Guan Ng, Ivan Ballesteros, et al. · Immunity · 68
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
2026 · Christina Düsing, Andrea-Hermina Györfi, et al. · Nature Medicine · 53
PDF
Inflammation induces pro-NETotic neutrophils via TNFR2 signaling
2022 · Friederike Neuenfeldt, Jan Christoph Schumacher, et al. · Cell Reports · 50
PDF
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
2025 · Fabian Müller, Nora Rebecca Schwingen, et al. · Blood · 47
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
2025 · Laura Bucci, Sebastian Böltz, et al. · New England Journal of Medicine · 45
Works count: 110
Citation count: 4,520
H-index: 29
I10-index: 36
Year
Topic
Type